HB1811
View on ILGACONTROLLED SUB-PMP-INTERSTATE
What this bill does
Amends the Illinois Controlled Substances Act concerning the Prescription Monitoring Program. Provides that interstate data sharing agreements shall be mutual. Provides that the Department of Human Services shall only share data if the reciprocal state provides equal access to data of the reciprocating state to all authorized users, licensed health care entities, and application vendors regardless of their method of connection to the Prescription Monitoring Program for interstate data sharing. Effective immediately.
Calculating prediction drivers...
Pipeline Progress
Current stage: Floor Vote · Last action 456 days ago · STAGNANT
How does a bill become law in Illinois?
-
Introduction of Bill
A member of the Senate or the House introduces a bill, which is assigned a unique identifying number (e.g., "H.B. ___" for House bills and "S.B. ___" for Senate bills). If not enacted, it must be reintroduced in the next General Assembly with a new number.
-
Committee Work — Hearings
The bill goes to the appropriate committee, which holds hearings to gather expert opinions and determine the need for the legislation.
-
Committee Work — Markup, Amendments, Report
The committee may make amendments to the bill. If approved, a committee report endorsing the bill is issued.
-
Floor Debate
The bill is debated and can be further amended. The debate transcripts are accessible online for public viewing.
-
Passage and Consideration in Second Chamber
If the bill passes in the first chamber, it moves to the second chamber for a similar review process. If both chambers approve, it goes to the governor.
-
Gubernatorial Action
The governor can sign the bill into law, veto it, or take no action (resulting in an automatic law after 60 days). The type of veto can be total or amendatory. Once signed, the bill becomes a Public Act and is assigned a Public Act number.
Sponsor Context
Bills sponsored by Natalie A. Manley advance 9% more often than the chamber average.
Public Engagement
Witness slips
22 slips filed. Proponent / opponent / no position as filed with the committee.
| Name | Organization | Representing | Position | Hearing committee | Hearing date |
|---|---|---|---|---|---|
| Cecelia Hylak-Reinholtz | C&G Consulting Partners, LLC | Logicoy | Proponent | Executive | 2025-03-20 |
| David Finney | Leap Orbit | Leap Orbit | Proponent | Executive | 2025-03-20 |
| Jean Hall | LogiCoy | Proponent | Executive | 2025-03-20 | |
| Margaret Vaughn | Margaret Vaughn Consulting | Self | Proponent | Executive | 2025-03-20 |
| David Finney | Leap Orbit LLC | Leap Orbit LLC | Proponent | Executive | 2025-03-19 |
| Margaret Vaughn | Margaret Vaughn Consulting | Illinois Certification Board | Proponent | Executive | 2025-03-19 |
| Jean Hall | LogiCoy Inc. | Proponent | Executive | 2025-03-12 | |
| Margaret Vaughn | Margaret Vaughn Consulting | Illinois Certification Board | Proponent | Executive | 2025-03-12 |
| Pusparaj Mohanty | Hanson Information Systems, Inc. | Pusparaj Mohanty | Proponent | Executive | 2025-03-12 |
| Robert Valuck | RxAssurance Corporation, dba OpiSafe | Representing my company, RxAssurance dba OpiSafe, based in Denver, CO but doing business nationwide | Proponent | Executive | 2025-03-12 |
| Stanley Tylman | none | Proponent | Executive | 2025-03-12 | |
| Margaret Vaughn | Margaret Vaughn Consulting | Illinois Certification Board | Proponent | Executive | 2025-03-05 |
| Anne Schaeffer | Mac Strategies Group | Bamboo Health | Opponent | Executive | 2025-03-20 |
| Jacob Cooper | Bamboo Health | Bamboo Health | Opponent | Executive | 2025-03-20 |
| Kara Slusser | INSPECT | Indiana Prescription Drug Monitoring Program | Opponent | Executive | 2025-03-20 |
| Matt Murphy | Mac Strategies | Bamboo Health | Opponent | Executive | 2025-03-20 |
| Rob Karr | Illinois Retail Merchants Association | Illinois Retail Merchants Association | Opponent | Executive | 2025-03-20 |
| Rob Karr | Illinois Retail Merchants Association | Illinois Retail Merchants Association | Opponent | Executive | 2025-03-19 |
| Rob Karr | Illinois Retail Merchants Association | Illinois Retail Merchants Association | Opponent | Executive | 2025-03-12 |
| David Finney | Leap Orbit | Leap Orbit | Proponent | Executive | 2025-04-09 |
| Jean Hall | LogiCoy | LogiCoy Inc. | Proponent | Executive | 2025-04-09 |
| Robert Valuck | RxAssurance Corporation - dba OpiSafe | RxAssurance Corporation (dba OpiSafe) | Proponent | Executive | 2025-04-09 |
Roll-call votes
Total votes and outcome per event. Deciding vote = margin of 1; those voters on the winning side could have changed the outcome by flipping.
| Date | Chamber | Type | Description | Yea | Nay | Present | NV | Outcome | Margin | Deciding voters |
|---|---|---|---|---|---|---|---|---|---|---|
| H | Committee | Executive | 8 | 4 | 0 | 0 | Passed | 4 | — |
Action History
13 actions recorded. Last action: 2025-04-11 — House Floor Amendment No. 1 Rule 19(c) / Re-referred toRules Committee. Each action's meaning and outcome signal are classified automatically.
All actions (table)
| Date | Chamber | Action | Category | Signal |
|---|---|---|---|---|
| 2025-01-28 | House | Filed with the Clerk byRep. Natalie A. Manley House Rule 6(b) | Introduction & Filing | — |
| 2025-01-28 | House | First Reading Senate Rule 5-1(d)/5-2; House Rule 37(d)/38 | Introduction & Filing | — |
| 2025-01-28 | House | Referred toRules Committee Senate Rule 3-8(a); House Rule 18(a) | Committee Assignment | — |
| 2025-02-25 | House | Assigned toExecutive Committee Senate Rule 3-8(a); House Rule 18(b) | Committee Assignment | — |
| 2025-03-20 | House | Do Pass / Short DebateExecutive Committee; 008-004-000 Senate Rule 3-11(a)(1); House Rule 22(a)(1), 52(b) | Committee Action | Positive |
| 2025-03-21 | House | Placed on Calendar 2nd Reading - Short Debate Senate Rule 4-4(7-8)/5-2; House Rule 31(8-9)/38/52 | Floor Process | Positive |
| 2025-03-26 | House | Second Reading - Short Debate Senate Rule 3-12(a)/5-4(a); House Rule 24(a)/40(b)/52(a)(1) | Floor Process | Positive |
| 2025-03-26 | House | Held on Calendar Order of Second Reading - Short Debate Senate Rule 4-4(7-8)/5-2; House Rule 31(8-9)/38/52 | Floor Process | — |
| 2025-04-07 | House | House Floor Amendment No. 1 Filed with Clerk byRep. Natalie A. Manley | Amendment Actions | — |
| 2025-04-07 | House | House Floor Amendment No. 1 Referred toRules Committee | Amendment Actions | — |
| 2025-04-08 | House | House Floor Amendment No. 1 Rules Refers toExecutive Committee | Amendment Actions | — |
| 2025-04-11 | House | Rule 19(a) / Re-referred toRules Committee House Rule 19(a); Senate analog: Rule 3-9(a) | Deadlines & Re-referrals | Mild − |
| 2025-04-11 | House | House Floor Amendment No. 1 Rule 19(c) / Re-referred toRules Committee | Amendment Actions | — |